z-logo
open-access-imgOpen Access
Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy
Author(s) -
Rajni K. Rao,
Uday Kumar,
Jill Schafer,
Esperanza Viloria,
David De Lurgio,
Elyse Foster
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.106.634444
Subject(s) - medicine , cardiac resynchronization therapy , cardiology , ventricular function , heart failure , systole , cardiac function curve , blood pressure , ejection fraction , diastole
Cardiac resynchronization therapy has emerged as an important therapy for advanced systolic heart failure. Among available cardiac resynchronization therapy pacing modes that restore ventricular synchrony, it is uncertain whether simultaneous biventricular (BiV), sequential BiV, or left ventricular (LV) pacing is superior. The Device Evaluation of CONTAK RENEWAL 2 and EASYTRAK 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF) trial is the first randomized trial comparing these 3 cardiac resynchronization therapy modalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom